Cost Matters Not Just in Cancer Care But In Other Diseases Too – Forbes

Further to the op-ed by Memorial Sloan-Kettering oncologists (A Hospital Says ‘No’ to an $11,000-a-Month Cancer Drug), more on how cost considerations are increasingly playing a role in deciding which drugs to use, and the requirement for better outcomes and benefits to justify additional cost. Quote: The Ben Goldacres of the world will claim that [...]